Xarelto lawsuit 2018. In May 2018, the FDA approved Andexxa, a drug that reverses the effects of Factor Xa inhibitors like Xarelto. 69 billion July 2018 J&J Talcum powder lawsuit In July of 2018, a lawsuit filed against Johnson & Johnson for damages caused by its talcum powder-based products was settled. As of November 2018. The company was confident that the lawsuits involving severe bleeding would stop due to the approval of the antidote. S. The drug company believed that so many patients sued because no antidote was available. Louis, Missouri. Mar 5, 2024 · In May 2018, the FDA approved Andexxa, a drug that reverses the effects of Factor Xa inhibitors like Xarelto. 3. Bayer and Johnson and Johnson have agreed to resolve virtually all the lawsuits filed in the US over their blood thinning medication Xarelto for a total of $775m. Due to a series of wins by in 2017 and 2018 the defendants, Johnson & Johnson and Bayer, the number of Xarelto lawsuits being filed are starting to slow down. This case involved 22 plaintiffs who claimed that the popular baby powders resulted in the development of ovarian cancer. Jan 10, 2018 · The verdict came in a lawsuit by Lynn Hartman, who was prescribed Xarelto to prevent strokes as a result of atrial fibrillation, an irregular heartbeat. XARELTO patent expiry, patent landscape, 505(b)2 developments, alternate formulations, international patents, generic entry, and drug patent litigation and lawsuits Xarelto is a part of a new class of anticoagulant (blood thinner) drugs that is associated with dangerous bleeding risks for which there is no antidote. 5 billion in revenues, although its sales fell slightly last year Xarelto lawsuits have been filed by patients who have suffered from internal bleeding, wound leakage, and infections after taking the drug. . This lawsuit joins growing multidistrict litigation (MDL) filed against the company. there were over 23,000 lawsuits pending against Johnson & Johnson alone. Aug 15, 2018 · Janssen Research & Development LLC, a Johnson & Johnson subsidiary, faces another lawsuit alleging severe side effects for Xarelto users. Others alleged their loved ones suffered fatal injuries as a consequence of taking the anti-clotting drug. In March 2019, a settlement resolved most outstanding Xarelto litigation. A jury convened in St. The FDA approved an antidote to Xarelto in May 2018. January 2018 Update: we just got a huge verdict that will change the course of this litigation forever What Were the Xarelto Lawsuits About The lawsuits against Bayer and Janssen Pharmaceuticals regarding Xarelto focused on serious allegations that the drug caused uncontrollable and sometimes fatal bleeding in patients. $4. Jan 7, 2026 · Background information on Xarelto lawsuits, settlements and litigation updates published between 2012 to 2018. Incredibly, even with accusations of court manipulation and a continuing onslaught of Xarelto lawsuits, the drug was approved in October 2018 for a new indication as a treatment for Chronic Coronary Artery Disease. This has led to many Xarelto lawsuits – both individual and class action claims – filed against manufacturers, Janssen Pharmaceuticals, Bayer, and Johnson & Johnson. Janssen holds a licence to sell rivaroxaban in the United States, while Bayer developed Thousands of patients who experienced bleeding while taking Xarelto have filed a Xarelto blood thinner lawsuit against the drug's manufacturers. Dec 11, 2025 · Thousands of patients who say they’ve been seriously injured by Xarelto (rivaroxaban) filed lawsuits against drug companies for compensation. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million, court documents on Monday showed. Xarelto, which is also known as rivaroxaban, was among Johnson & Johnson’s top-selling products in 2018, bringing in nearly $2. Mar 25, 2019 · Johnson & Johnson and Bayer, the manufacturers of rivaroxaban (sold as Xarelto), have agreed to pay $775 million to settle thousands of lawsuits over failure to warn consumers about the risk of potentially fatal internal bleeding. Thousands of users have sued Janssen Pharmaceuticals and Bayer Healthcare claiming they suffered internal bleeding after taking the popular blood thinner Xarelto. Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U. The German drug maker Bayer and the Johnson & Johnson subsidiary Janssen Pharmaceuticals will jointly pay $775m (£587m; €687m) to settle more than 25 000 lawsuits in US federal and state courts, representing almost all of the outstanding claims against the bestselling anticoagulant rivaroxaban (Xarelto). The drug’s makers have won six trials, but the settlement in March 2019 indicates that they are willing to compensate patients who have been harmed by the drug. ztgfur, xnncg, nrcf, oflh, sutse, e1mu, hy7pjz, zzpa1p, nyptvi, msuu,